KT Tape, a company that deals with drug-free pain relief, has launched its KT Recovery+ Wave, it was reported on Monday.
The company says that the product is a clinically proven and FDA approved wearable device that offers drug-free pain relief for sports injuries, knee pain, arthritis, back pain, carpal tunnel, sprains and more.
The new KT Recovery+ Wave utilises sensation-free electromagnetic pulses called pulsed shortwave therapy to decrease nerve hypersensitivity and relieve pain. It has a guaranteed battery life of 250 hours and is available at an MSRP of USD34.99.
DATROWAY receives US priority review for first-line metastatic triple negative breast cancer
Lupin launches Dasatinib tablets in US market
Natera submits Signatera CDx PMA to FDA for bladder cancer use
Pharming receives FDA complete response letter for paediatric Joenja application
Trace Biosciences' IND application for nerve-specific imaging agent approved by FDA
Frontage expands early phase clinical research capabilities across US and China
MicuRx Pharmaceuticals' IND application for MRX-5 cleared by FDA
FDA approves Tenpoint Therapeutics' YUVEZZI as first dual-agent eye drop for presbyopia
Summit Therapeutics' BLA for ivonescimab in EGFR-mutated NSCLC accepted by FDA
WuXi Biologics collaborates with Sinorda Biomedicine for antibody development
Biogen's litifilimab receives FDA Breakthrough Therapy Designation for CLE
Glaukos receives FDA approval for repeat administration of iDose TR
Guerbet's contrast agent Elucirem approved by European Commission in children from birth
Spine Innovation's LOGIC Titanium Implant System receives US FDA 510(k) market approval